$NBIS

Forget CoreWeave — This Is the AI Stock You Should Instead Be Buying

Nebius (NBIS) reported 454% revenue growth last quarter, with $8B cash and near-zero debt. It has contracts with Microsoft (MSFT) and Meta (META) potentially worth $19B and $27B, supported by a $4B NVIDIA (NVDA) stake. CoreWeave (CRWV) reported $2.575B Q2 revenue but widened net loss to $626M and high debt levels.

Original reporting
Published Aug 24, 2026, 6:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 24, 2026, 6:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Forget CoreWeave — This Is the AI Stock You Should Instead Be Buying — source image
Decision brief

The 30-second read

$NBISBullishHigh
01

Why it matters

Nebius's new contracts and cash reserves could attract capital from investors seeking lower risk exposure in the AI sector, while CoreWeave's widening losses may deter risk‑averse traders.

02

Market read

The contrasting financial profiles of Nebius and CoreWeave provide a clear trade theme within the AI infrastructure space.

03

What to watch

Potential regulatory or supply‑chain risks for Nebius's rapid expansion.

Relevance 8/10Novelty 8/10Timing: today

Background

The article compares two AI‑infrastructure providers, positioning Nebius as a financially cleaner alternative to CoreWeave.

Company-level read

Ticker impact

$NBISBullishHigh confidence
Context

Nebius disclosed $8.04 bn cash, near‑zero debt and Q2 revenue up 454% with major Microsoft, Meta and NVIDIA contracts.

Expected impact

Potential price appreciation as investors re‑price AI‑cloud exposure.

Evidence & confidence

New contract values and cash position are material and not previously reported.

$CRWVBearishHigh confidence
Context

CoreWeave reported Q2 revenue of $2.575 bn, widening net loss and high debt, highlighting financial strain.

Expected impact

Possible downside pressure amid widening losses and debt load.

Evidence & confidence

Fresh loss figures and debt guidance are primary disclosures.

Market effects

Highlights competitive dynamics in the AI‑cloud infrastructure sector.

U.S. AI‑cloud stocks may see re‑allocation based on balance‑sheet contrasts.

Large hyperscaler contracts underscore global AI infrastructure demand.

Counterpoint

CoreWeave's growth may still justify a premium despite debt if AI demand accelerates.

Key entities

  • Nebius

    AI cloud provider with large hyperscaler contracts and strong balance sheet.

  • CoreWeave

    AI infrastructure firm facing high debt and widening losses.

Related articles

$CRWVMedAI 8/10

AI Infrastructure Stocks Surge: How Long Can CoreWeave (CRWV) and Super Micro Computer (SMCI) Keep It Up?

CoreWeave (CRWV) and Super Micro Computer (SMCI) shares surged to 3-month highs after both companies issued strong forecasts, signaling high demand for AI computing. CRWV raised revenue and profit forecasts, with a revenue backlog of $104.2B. SMCI exceeded revenue estimates and improved gross margins. Both companies benefit from AI infrastructure growth but face risks related to debt and market volatility.

$NBISHighAI 8/10

Why is Nebius stock sliding today?

Nebius (NBIS) shares fell 7.1% to $203.49 due to the settlement of a $5B convertible notes offering, raising dilution concerns. The company also exchanged $800M in notes for 15.8M new shares, adding supply pressure. Insider sales and a broader market decline also impacted the stock, despite strong AI cloud business growth.

$NBISMedAI 8/10

Is Nebius Overvalued or Digesting Debt for Something BIgger and Better?

Nebius Group (NBIS) stock fell 21.09% after Q2 results, despite revenue growth of 454% YoY to $582.30M. The company faces debate over its high valuation and debt. Bulls highlight strong demand and multi-year revenue visibility, while bears point to significant liabilities and operating losses. Analysts' price target is $283.93, with mixed ratings. Key catalysts include Q3 results and funding strategies.

$NBISMed

3 Growth Stocks to Buy Before Wall Street Catches On

Nebius (NBIS) reported 454% revenue growth and a $37.5B backlog, with Meta and NVIDIA deals. Symbotic (SYM) trades near 52-week lows despite a $22.5B backlog. Centrus Energy (LEU) beat Q2 EPS by 93% with a $4.5B backlog. All three companies show high growth but trade below consensus targets.